Your opinion matters. We've officially kicked off our third annual MedTech Dive reader survey and we want to hear from you.
The feedback you provide will directly inform the journalism you see in the newsletter and on our site. The survey should take about five minutes to complete and will help us serve you better. Plus, all respondents will be entered to win a $200 gift card of your choice.
Take the survey
If you've already completed the survey, thank you. We look forward to reviewing your responses.
Thanks again for reading, supporting, and trusting our publications. Sean Griffey CEO Industry Dive Twitter | Email The president signed an order last month seeking to bolster the nation's cyber posture amid growing threats from hackers. | CEO Geoff Martha has boasted the nod for SenSight will help it close "a key competitive gap." The medtech competes with Abbott and Boston Scientific in the market. | As the pandemic intensified, the tech behemoth initiated an in-house COVID-19 testing service for employees, initially in the U.S. and later in the U.K. | Social distancing mandates ramped up interest in delivering healthcare online. | The agency's recent breakthrough designations feature a clutch of oncology devices and diagnostics from companies including Viome and Avenda Health. | The move comes as regulators scrutinize a $7.1 billion buyout bid by Illumina. Grail will face the challenge of getting insurers' support while competing with Guardant Health, Exact Sciences and Freenome. | MedTech leaders face rising pressures from health care providers and growing competition, in addition to stringent regulations. Discover how adopting digital technologies can help in this webinar. | | From Our Library Webinar - on demand Aquant | Webinar - on demand MasterControl | View all resources Best of What We're Reading Wall Street Journal | Politico | The Verge | Science | MedPage Today | MobiHealthNews | Dive Into a Topic |
0 Comments